(Q36424972)

14 August 2017

Large granular lymphocytosis with severe neutropenia following ipilimumab therapy for metastatic melanoma (English)

1 reference

14 August 2017

0 references

1 reference

Guoqing Wei

1

1 reference

14 August 2017

Uzoma Nwakuche

2

1 reference

14 August 2017

Gustavo Cadavid

3

1 reference

14 August 2017

Asim Ajaz

4

1 reference

14 August 2017

Karen Seiter

5

1 reference

14 August 2017

Delong Liu

6

1 reference

14 August 2017

26 March 2012

1 reference

Experimental Hematology & Oncology

14 August 2017

1 reference

14 August 2017

1

1 reference

14 August 2017

1

1 reference

14 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1186/2162-3619-1-3

14 August 2017

0 references

cites work

Current management and novel agents for malignant melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506991

PubMed Central

reference URL

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506991

PubMed Central

reference URL

Neutropenia in a patient treated with ipilimumab (anti-CTLA-4 antibody).

30 September 2017

1 reference

https://api.crossref.org/works/10.1186%2F2162-3619-1-3

Crossref

reference URL

21 January 2018

Identifiers

DOI

10.1186/2162-3619-1-3

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference

14 August 2017

PubMed publication ID

23210632

1 reference